NIOSH WTC Health Program Research Funding

NIOSH WTC Health Program Research Funding sits under the National Institute for Occupational Safety and Health, the CDC institute inside the U.S. Department of Health and Human Services. The program funds research tied to the 9/11-exposed population through the World Trade Center Health Program, which was established under the James Zadroga 9/11 Health and Compensation Act. The current cycle uses several research mechanisms. U01 cooperative agreements support clinical, treatment, and diagnostic research on World Trade Center-related conditions; R21 awards support early-stage exploratory work on new approaches and methods; K01 awards support mentored career development for younger investigators; and U50 support continues the World Trade Center Health Registry. The FY 2026 cycle includes RFA-OH-26-001 and RFA-OH-26-015, while the U50 line had already passed its February 20, 2026 deadline when the source was captured. Award amounts are not posted on the CDC summary page. This route fits researchers and institutions with a direct WTC health focus, especially teams able to connect clinical questions, treatment impact, or registry work to the exposed cohort. The program is broad on applicant type but narrow in topic, and it works best for applicants that can show a precise contribution to WTC-related evidence, care, or diagnostics rather than general occupational health research.

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.